At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 338 enrolled
Drug / intervention
SUPREP Bowel Prep Kit +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
In Brief
A Phase 4 clinical trial evaluating SUPREP Bowel Prep Kit and FDA approved bowel preparation containing electrolytes for Colonoscopy and 2 related conditions. Completed, enrolled 338 participants across 10 sites.
Detailed Summary
To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy, Bowel Preparation, Endoscopy
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedFeb 2013
Primary CompletionMay 2013
TodayJul 2026
First PostedFeb 8, 2013
Enrollment StartDec 1, 2012
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.4 years ago
Interventions
SUPREP Bowel Prep Kitdrug
solution for oral administration prior to colonoscopy
FDA approved bowel preparation containing electrolytesdrug
solution for oral administration prior to colonoscopy